These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 3486090

  • 1. Parkinson's disease.
    Lieberman AN.
    Compr Ther; 1986 Mar; 12(3):25-9. PubMed ID: 3486090
    [No Abstract] [Full Text] [Related]

  • 2. Parkinson's disease in 1984: an update.
    Lang AE, Blair RD.
    Can Med Assoc J; 1984 Nov 01; 131(9):1031-7. PubMed ID: 6388779
    [Abstract] [Full Text] [Related]

  • 3. [Therapy of Parkinson's disease. Practical criteria of treatment].
    Casacchia M, Carolei A, Zamponi A, Agnoli A, Fazio C.
    Recenti Prog Med; 1976 May 01; 60(5):567-84. PubMed ID: 14360
    [No Abstract] [Full Text] [Related]

  • 4. MAO type B inhibitors as adjunct to L-dopa therapy.
    Youdim MB, Finberg JP.
    Adv Neurol; 1987 May 01; 45():127-36. PubMed ID: 3103383
    [No Abstract] [Full Text] [Related]

  • 5. [Therapy of Parkinson's syndrome].
    Clemens R.
    Dtsch Med Wochenschr; 1976 Mar 12; 101(11):420-3. PubMed ID: 767084
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacotherapy: problems and practices.
    Muenter MD.
    Clin Neuropharmacol; 1986 Mar 12; 9 Suppl 1():S23-36. PubMed ID: 3708606
    [Abstract] [Full Text] [Related]

  • 11. R-(-)-deprenyl and parkinsonism.
    Yahr MD.
    J Neural Transm Suppl; 1987 Mar 12; 25():5-12. PubMed ID: 3123605
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.
    Muñoz A, Li Q, Gardoni F, Marcello E, Qin C, Carlsson T, Kirik D, Di Luca M, Björklund A, Bezard E, Carta M.
    Brain; 2008 Dec 12; 131(Pt 12):3380-94. PubMed ID: 18952677
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Antiparkinsonian drugs (author's transl)].
    Ando K.
    No To Shinkei; 1980 Aug 12; 32(8):743-53. PubMed ID: 7008813
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MPTP: clinical implications.
    Stern G.
    J Neural Transm Suppl; 1986 Aug 12; 20():77-81. PubMed ID: 3091763
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.